 "Divi's Laboratories")
Divi's Laboratories on Monday said its consolidated net profit declined by 18 per cent to Rs 494 crore in the second quarter of the current financial year.
The drug firm had reported a net profit of Rs 606 crore in the July-September period of last fiscal.
Revenue from operations declined to Rs 1,854 crore in the September quarter as against Rs 1,987 crore in the year-ago period.
Shares of the company on Monday ended 8.63 per cent at Rs 3,422 apiece on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
